ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Cancer Control Planning Conference Delayed To 1977

August 13, 1976

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

November 9, 1979

Group Chairs Respond to Center Directors’ White Paper

April 1, 2011

In Brief: ‘WSJ” Articles Call Attention To Problems With Cancer Program Knipmeyer to Leave NCI

May 19, 1989

Funding Opportunities: ACS Calif. Division Calls for Applications

August 1, 1997

California Hospital Raises $22 Million For New Cancer Center

September 14, 1990